Ocular Therapeutix
OCUL
$5.87
Share price
16.93%
Change (1 day)
-5.02%
Change (1 year)
Categories
P/S ratio for Ocular Therapeutix (OCUL)
P/S ratio as of May 2024 (TTM): 13.3
According to Ocular Therapeutix's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 13.2905. At the end of 2023 the company had a P/S ratio of 8.76.
P/S ratio history for Ocular Therapeutix from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 8.76 | 108.54% |
| 2022 | 4.20 | -65.75% |
| 2021 | 12.3 | -86.43% |
| 2020 | 90.4 | 92.18% |
| 2019 | 47.0 | -43.36% |
| 2018 | 83.0 | 21.9% |
| 2017 | 68.1 | -38.27% |
| 2016 | 110 | -16.72% |
| 2015 | 133 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | 3.43 | -74.17% | 🇺🇸 USA |
 Anika Therapeutics ANIK | 2.36 | -82.27% | 🇺🇸 USA |
 Intersect ENT XENT | N/A | N/A | 🇺🇸 USA |
 Haemonetics HAE | 3.68 | -72.28% | 🇺🇸 USA |